Predictive Immunologic Markers of Response to Nivolumab in Non-Small Cell Lung Cancer

被引：1

作者：

Genova, Carlo ^{[1
]}

Carrega, Paolo ^{[2
]}

Distefano, Roberta ^{[1
]}

Ottonello, Selene ^{[3
]}

Pietra, Gabriella ^{[3
]}

Cossu, Irene ^{[2
]}

Rijavec, Erika ^{[1
]}

Biello, Federica ^{[1
]}

Rossi, Giovanni ^{[1
]}

Barletta, Giulia ^{[1
]}

Dal Bello, Maria Giovanna ^{[1
]}

Alama, Angela ^{[1
]}

Coco, Simona ^{[1
]}

Vanni, Irene ^{[1
]}

Maggioni, Claudia ^{[1
]}

Merlo, Franco ^{[4
]}

Mingari, Maria Cristina ^{[3
]}

Grosse, Francesco ^{[1
]}

机构：

[1] San Martino Hosp, Natl Inst Canc Res, Lung Canc Unit, Genoa, Italy

[2] Giannina Gaslini Inst, Lab Clin & Expt Immunol, Genoa, Italy

[3] San Martino Hosp, Natl Inst Canc Res, Dept Expt Med, Genoa, Italy

[4] San Martino Hosp, Natl Inst Canc Res, Clin Trials Unit, Genoa, Italy

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

local cancerimmunotherapy; Lewis lung cancer; photoimmunotherapy; regulatory T cell;

D O I：

10.1016/j.jtho.2016.11.1867

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.02c-072

引用

页码：S1320 / S1321

页数：3

共 50 条

[1] Evaluating inflammatory markers as predictive tools for advanced non-small cell lung cancer receiving nivolumab Predictive markers for nivolumab response in advanced NSCLC
Karaboyun, Kubilay
[J]. ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14 : 361 - 365
[2] Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non-small Cell Lung Cancer
Kataoka, Yuki
Hirano, Katsuya
Narabayashi, Tomoko
Hara, Satoshi
Fujimoto, Daichi
Tanaka, Tae
Ebi, Noriyuki
Tomii, Keisuke
Yoshioka, Hiroshige
[J]. ANTICANCER RESEARCH, 2018, 38 (01) : 559 - 563
[3] Predictive molecular markers in non-small cell lung cancer
Rosell, R
Tarón, M
O'Brate, A
[J]. CURRENT OPINION IN ONCOLOGY, 2001, 13 (02) : 101 - 109
[4] Predictive Value of Computed Tomography Characteristics for Nivolumab Response in Pretreated Non-Small Cell Lung Cancer
Imai, H.
Minemura, H.
Moriya, H.
Sugiyama, T.
Yamada, Y.
Higuchi, M.
Kaira, K.
Ozaki, Y.
Kanazawa, K.
Yokouchi, H.
Kasai, T.
Kaburagi, T.
Suzuki, H.
Minato, K.
Shibata, Y.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S883 - S884
[5] Predictive Biomarkers of Response to Nivolumab in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study
Kataoka, Y.
Hirano, K.
Narabayashi, T.
Hara, S.
Fujimoto, D.
Tanaka, T.
Ebi, N.
Tomii, K.
Yoshioka, H.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1995 - S1995
[6] Predictive markers in the adjuvant therapy of non-small cell lung cancer
Filipits, Martin
Pirker, Robert
[J]. LUNG CANCER, 2011, 74 (03) : 355 - 363
[7] Clinical Predictive Markers of Response to Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
Rhone, R.
Raez, L.
Dumais, K.
Powery, H.
Gentile, F.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1083 - S1083
[8] Lung Tissue Injury as an Atypical Response to Nivolumab in Non-Small Cell Lung Cancer
Rampinelli, Cristiano
Spitaleri, Gianluca
Passaro, Antonio
Pochesci, Alessia
Ancona, Eleonora
De Marinis, Filippo
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (10) : 1349 - 1350
[9] Nivolumab for treating non-small cell lung cancer
Guibert, Nicolas
Mazieres, Julien
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1789 - 1797
[10] Nivolumab and Pembrolizumab for Non-Small Cell Lung Cancer
Morgensztern, Daniel
Herbst, Roy S.
[J]. CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3713 - 3717

← 1 2 3 4 5 →